nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—CYP2D6—Lomustine—brain cancer	0.145	0.569	CbGbCtD
Zuclopenthixol—CYP2D6—Hydroxyurea—brain cancer	0.11	0.431	CbGbCtD
Zuclopenthixol—HTR2A—choroid plexus—brain cancer	0.0221	0.0706	CbGeAlD
Zuclopenthixol—HRH1—nose—brain cancer	0.017	0.0545	CbGeAlD
Zuclopenthixol—DRD1—telencephalic ventricle—brain cancer	0.0166	0.0531	CbGeAlD
Zuclopenthixol—HTR6—ganglion—brain cancer	0.0139	0.0444	CbGeAlD
Zuclopenthixol—DRD5—ganglion—brain cancer	0.0135	0.0433	CbGeAlD
Zuclopenthixol—HTR2A—trigeminal nerve—brain cancer	0.0112	0.0357	CbGeAlD
Zuclopenthixol—HTR2A—cerebellar cortex—brain cancer	0.0111	0.0356	CbGeAlD
Zuclopenthixol—DRD1—ganglion—brain cancer	0.0103	0.033	CbGeAlD
Zuclopenthixol—HTR2A—vein—brain cancer	0.0101	0.0323	CbGeAlD
Zuclopenthixol—DRD2—telencephalic ventricle—brain cancer	0.0098	0.0314	CbGeAlD
Zuclopenthixol—HTR2A—cranial nerve—brain cancer	0.00795	0.0254	CbGeAlD
Zuclopenthixol—HTR2A—pons—brain cancer	0.00786	0.0251	CbGeAlD
Zuclopenthixol—Trifluoperazine—S100A4—brain cancer	0.00773	0.708	CrCbGaD
Zuclopenthixol—HTR2A—telencephalic ventricle—brain cancer	0.00646	0.0207	CbGeAlD
Zuclopenthixol—DRD2—ganglion—brain cancer	0.0061	0.0195	CbGeAlD
Zuclopenthixol—HTR2A—pineal body—brain cancer	0.00561	0.0179	CbGeAlD
Zuclopenthixol—HTR6—telencephalon—brain cancer	0.00536	0.0171	CbGeAlD
Zuclopenthixol—DRD5—telencephalon—brain cancer	0.00521	0.0167	CbGeAlD
Zuclopenthixol—ADRA1A—hindbrain—brain cancer	0.00472	0.0151	CbGeAlD
Zuclopenthixol—DRD2—hindbrain—brain cancer	0.00463	0.0148	CbGeAlD
Zuclopenthixol—DRD1—brainstem—brain cancer	0.00449	0.0144	CbGeAlD
Zuclopenthixol—HTR2A—ganglion—brain cancer	0.00402	0.0129	CbGeAlD
Zuclopenthixol—DRD1—telencephalon—brain cancer	0.00398	0.0127	CbGeAlD
Zuclopenthixol—HTR2A—endothelium—brain cancer	0.00347	0.0111	CbGeAlD
Zuclopenthixol—HTR6—head—brain cancer	0.00333	0.0107	CbGeAlD
Zuclopenthixol—DRD5—endocrine gland—brain cancer	0.00329	0.0105	CbGeAlD
Zuclopenthixol—DRD5—head—brain cancer	0.00325	0.0104	CbGeAlD
Zuclopenthixol—HTR2A—blood vessel—brain cancer	0.0032	0.0102	CbGeAlD
Zuclopenthixol—HTR2A—hindbrain—brain cancer	0.00305	0.00977	CbGeAlD
Zuclopenthixol—HTR6—central nervous system—brain cancer	0.00304	0.00974	CbGeAlD
Zuclopenthixol—DRD5—central nervous system—brain cancer	0.00296	0.00948	CbGeAlD
Zuclopenthixol—DRD1—midbrain—brain cancer	0.00286	0.00916	CbGeAlD
Zuclopenthixol—CYP2D6—hindbrain—brain cancer	0.00278	0.0089	CbGeAlD
Zuclopenthixol—ADRA1A—brainstem—brain cancer	0.00271	0.00866	CbGeAlD
Zuclopenthixol—DRD2—brainstem—brain cancer	0.00265	0.00849	CbGeAlD
Zuclopenthixol—DRD1—head—brain cancer	0.00248	0.00794	CbGeAlD
Zuclopenthixol—HTR6—brain—brain cancer	0.00242	0.00773	CbGeAlD
Zuclopenthixol—ADRA1A—telencephalon—brain cancer	0.0024	0.00768	CbGeAlD
Zuclopenthixol—DRD2—telencephalon—brain cancer	0.00235	0.00753	CbGeAlD
Zuclopenthixol—DRD5—brain—brain cancer	0.00235	0.00753	CbGeAlD
Zuclopenthixol—DRD1—central nervous system—brain cancer	0.00226	0.00725	CbGeAlD
Zuclopenthixol—DRD2—pituitary gland—brain cancer	0.00192	0.00613	CbGeAlD
Zuclopenthixol—HRH1—telencephalon—brain cancer	0.00186	0.00595	CbGeAlD
Zuclopenthixol—Purpura—Temozolomide—brain cancer	0.00185	0.00462	CcSEcCtD
Zuclopenthixol—Dysuria—Hydroxyurea—brain cancer	0.00185	0.0046	CcSEcCtD
Zuclopenthixol—Neutropenia—Hydroxyurea—brain cancer	0.00185	0.0046	CcSEcCtD
Zuclopenthixol—Arrhythmia—Procarbazine—brain cancer	0.00183	0.00455	CcSEcCtD
Zuclopenthixol—ADRA2A—telencephalon—brain cancer	0.00183	0.00584	CbGeAlD
Zuclopenthixol—Body temperature increased—Lomustine—brain cancer	0.00181	0.0045	CcSEcCtD
Zuclopenthixol—Weight increased—Hydroxyurea—brain cancer	0.0018	0.00448	CcSEcCtD
Zuclopenthixol—DRD1—brain—brain cancer	0.0018	0.00575	CbGeAlD
Zuclopenthixol—Drowsiness—Hydroxyurea—brain cancer	0.00176	0.00439	CcSEcCtD
Zuclopenthixol—HTR2A—brainstem—brain cancer	0.00175	0.0056	CbGeAlD
Zuclopenthixol—Tension—Procarbazine—brain cancer	0.00175	0.00435	CcSEcCtD
Zuclopenthixol—Ataxia—Carmustine—brain cancer	0.00174	0.00433	CcSEcCtD
Zuclopenthixol—Nervousness—Procarbazine—brain cancer	0.00173	0.00431	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Carmustine—brain cancer	0.00171	0.00425	CcSEcCtD
Zuclopenthixol—DRD2—midbrain—brain cancer	0.00169	0.00541	CbGeAlD
Zuclopenthixol—Ataxia—Temozolomide—brain cancer	0.00168	0.00418	CcSEcCtD
Zuclopenthixol—Tremor—Procarbazine—brain cancer	0.00167	0.00415	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00167	0.00415	CcSEcCtD
Zuclopenthixol—Breast disorder—Temozolomide—brain cancer	0.00161	0.00402	CcSEcCtD
Zuclopenthixol—Syncope—Procarbazine—brain cancer	0.0016	0.00397	CcSEcCtD
Zuclopenthixol—CYP2D6—brainstem—brain cancer	0.00159	0.0051	CbGeAlD
Zuclopenthixol—Leukopenia—Procarbazine—brain cancer	0.00159	0.00397	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00158	0.00392	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Procarbazine—brain cancer	0.00156	0.0039	CcSEcCtD
Zuclopenthixol—HTR2A—telencephalon—brain cancer	0.00155	0.00497	CbGeAlD
Zuclopenthixol—Convulsion—Procarbazine—brain cancer	0.00154	0.00384	CcSEcCtD
Zuclopenthixol—Hypertension—Procarbazine—brain cancer	0.00154	0.00383	CcSEcCtD
Zuclopenthixol—ADRA2A—gonad—brain cancer	0.00152	0.00488	CbGeAlD
Zuclopenthixol—Pancytopenia—Carmustine—brain cancer	0.00152	0.00378	CcSEcCtD
Zuclopenthixol—Myalgia—Procarbazine—brain cancer	0.00151	0.00377	CcSEcCtD
Zuclopenthixol—ADRA1A—endocrine gland—brain cancer	0.00151	0.00485	CbGeAlD
Zuclopenthixol—Anxiety—Procarbazine—brain cancer	0.00151	0.00376	CcSEcCtD
Zuclopenthixol—Sweating increased—Temozolomide—brain cancer	0.0015	0.00375	CcSEcCtD
Zuclopenthixol—ADRA1A—head—brain cancer	0.0015	0.00479	CbGeAlD
Zuclopenthixol—Neutropenia—Carmustine—brain cancer	0.00149	0.00372	CcSEcCtD
Zuclopenthixol—ADRA2A—pituitary gland—brain cancer	0.00149	0.00476	CbGeAlD
Zuclopenthixol—DRD2—endocrine gland—brain cancer	0.00148	0.00475	CbGeAlD
Zuclopenthixol—Dry mouth—Procarbazine—brain cancer	0.00148	0.00369	CcSEcCtD
Zuclopenthixol—Pancytopenia—Temozolomide—brain cancer	0.00147	0.00365	CcSEcCtD
Zuclopenthixol—DRD2—head—brain cancer	0.00147	0.00469	CbGeAlD
Zuclopenthixol—Vomiting—Lomustine—brain cancer	0.00145	0.00362	CcSEcCtD
Zuclopenthixol—Neutropenia—Temozolomide—brain cancer	0.00144	0.0036	CcSEcCtD
Zuclopenthixol—Dysuria—Temozolomide—brain cancer	0.00144	0.0036	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Carmustine—brain cancer	0.00144	0.00359	CcSEcCtD
Zuclopenthixol—Angiopathy—Hydroxyurea—brain cancer	0.00144	0.00358	CcSEcCtD
Zuclopenthixol—ADRA2A—medulla oblongata—brain cancer	0.00143	0.00459	CbGeAlD
Zuclopenthixol—Shock—Procarbazine—brain cancer	0.00143	0.00356	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Temozolomide—brain cancer	0.00142	0.00354	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Procarbazine—brain cancer	0.00142	0.00354	CcSEcCtD
Zuclopenthixol—Tachycardia—Procarbazine—brain cancer	0.00142	0.00353	CcSEcCtD
Zuclopenthixol—CYP2D6—telencephalon—brain cancer	0.00141	0.00453	CbGeAlD
Zuclopenthixol—Photosensitivity reaction—Temozolomide—brain cancer	0.00141	0.00351	CcSEcCtD
Zuclopenthixol—Weight increased—Temozolomide—brain cancer	0.00141	0.0035	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Procarbazine—brain cancer	0.0014	0.0035	CcSEcCtD
Zuclopenthixol—Weight decreased—Temozolomide—brain cancer	0.0014	0.00348	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Temozolomide—brain cancer	0.00139	0.00347	CcSEcCtD
Zuclopenthixol—Anorexia—Procarbazine—brain cancer	0.00138	0.00345	CcSEcCtD
Zuclopenthixol—Erythema—Hydroxyurea—brain cancer	0.00138	0.00343	CcSEcCtD
Zuclopenthixol—ADRA1A—central nervous system—brain cancer	0.00136	0.00437	CbGeAlD
Zuclopenthixol—Nausea—Lomustine—brain cancer	0.00136	0.00338	CcSEcCtD
Zuclopenthixol—Hypotension—Procarbazine—brain cancer	0.00136	0.00338	CcSEcCtD
Zuclopenthixol—DRD2—central nervous system—brain cancer	0.00134	0.00428	CbGeAlD
Zuclopenthixol—ADRA1A—cerebellum—brain cancer	0.00133	0.00427	CbGeAlD
Zuclopenthixol—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00132	0.0033	CcSEcCtD
Zuclopenthixol—Insomnia—Procarbazine—brain cancer	0.00131	0.00327	CcSEcCtD
Zuclopenthixol—ADRA2A—midbrain—brain cancer	0.00131	0.0042	CbGeAlD
Zuclopenthixol—DRD2—cerebellum—brain cancer	0.00131	0.00418	CbGeAlD
Zuclopenthixol—Paraesthesia—Procarbazine—brain cancer	0.0013	0.00325	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Temozolomide—brain cancer	0.0013	0.00324	CcSEcCtD
Zuclopenthixol—HTR2A—gonad—brain cancer	0.0013	0.00415	CbGeAlD
Zuclopenthixol—Somnolence—Procarbazine—brain cancer	0.00129	0.00322	CcSEcCtD
Zuclopenthixol—ADRA2A—spinal cord—brain cancer	0.00128	0.00409	CbGeAlD
Zuclopenthixol—Ill-defined disorder—Hydroxyurea—brain cancer	0.00128	0.00318	CcSEcCtD
Zuclopenthixol—HTR2A—pituitary gland—brain cancer	0.00126	0.00405	CbGeAlD
Zuclopenthixol—Decreased appetite—Procarbazine—brain cancer	0.00126	0.00314	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Etoposide—brain cancer	0.00126	0.00314	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Carmustine—brain cancer	0.00126	0.00314	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Carmustine—brain cancer	0.00126	0.00313	CcSEcCtD
Zuclopenthixol—Fatigue—Procarbazine—brain cancer	0.00125	0.00312	CcSEcCtD
Zuclopenthixol—Malaise—Hydroxyurea—brain cancer	0.00124	0.00309	CcSEcCtD
Zuclopenthixol—Pain—Procarbazine—brain cancer	0.00124	0.00309	CcSEcCtD
Zuclopenthixol—Constipation—Procarbazine—brain cancer	0.00124	0.00309	CcSEcCtD
Zuclopenthixol—Leukopenia—Hydroxyurea—brain cancer	0.00123	0.00307	CcSEcCtD
Zuclopenthixol—Visual impairment—Carmustine—brain cancer	0.00123	0.00307	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Temozolomide—brain cancer	0.00122	0.00304	CcSEcCtD
Zuclopenthixol—HTR2A—medulla oblongata—brain cancer	0.00122	0.0039	CbGeAlD
Zuclopenthixol—Oedema peripheral—Temozolomide—brain cancer	0.00122	0.00303	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Temozolomide—brain cancer	0.00121	0.00303	CcSEcCtD
Zuclopenthixol—Urethral disorder—Temozolomide—brain cancer	0.00121	0.00302	CcSEcCtD
Zuclopenthixol—Sweating increased—Etoposide—brain cancer	0.0012	0.003	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Procarbazine—brain cancer	0.0012	0.00298	CcSEcCtD
Zuclopenthixol—Eye disorder—Carmustine—brain cancer	0.0012	0.00298	CcSEcCtD
Zuclopenthixol—Convulsion—Hydroxyurea—brain cancer	0.00119	0.00297	CcSEcCtD
Zuclopenthixol—Visual impairment—Temozolomide—brain cancer	0.00119	0.00297	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Procarbazine—brain cancer	0.00119	0.00296	CcSEcCtD
Zuclopenthixol—Thioridazine—CYP2C9—brain cancer	0.00118	0.109	CrCbGaD
Zuclopenthixol—Pancytopenia—Etoposide—brain cancer	0.00117	0.00292	CcSEcCtD
Zuclopenthixol—HRH1—endocrine gland—brain cancer	0.00117	0.00375	CbGeAlD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00116	0.0029	CcSEcCtD
Zuclopenthixol—Discomfort—Hydroxyurea—brain cancer	0.00116	0.00289	CcSEcCtD
Zuclopenthixol—HRH1—head—brain cancer	0.00116	0.0037	CbGeAlD
Zuclopenthixol—Neutropenia—Etoposide—brain cancer	0.00116	0.00288	CcSEcCtD
Zuclopenthixol—Eye disorder—Temozolomide—brain cancer	0.00115	0.00288	CcSEcCtD
Zuclopenthixol—Tinnitus—Temozolomide—brain cancer	0.00115	0.00287	CcSEcCtD
Zuclopenthixol—ADRA2A—endocrine gland—brain cancer	0.00115	0.00369	CbGeAlD
Zuclopenthixol—Abdominal pain—Procarbazine—brain cancer	0.00115	0.00286	CcSEcCtD
Zuclopenthixol—Body temperature increased—Procarbazine—brain cancer	0.00115	0.00286	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Temozolomide—brain cancer	0.00115	0.00286	CcSEcCtD
Zuclopenthixol—Arrhythmia—Carmustine—brain cancer	0.00114	0.00285	CcSEcCtD
Zuclopenthixol—ADRA2A—head—brain cancer	0.00114	0.00364	CbGeAlD
Zuclopenthixol—Angiopathy—Temozolomide—brain cancer	0.00112	0.00279	CcSEcCtD
Zuclopenthixol—Mental disorder—Carmustine—brain cancer	0.00112	0.00279	CcSEcCtD
Zuclopenthixol—Immune system disorder—Temozolomide—brain cancer	0.00112	0.00278	CcSEcCtD
Zuclopenthixol—HTR2A—midbrain—brain cancer	0.00111	0.00357	CbGeAlD
Zuclopenthixol—Erythema—Carmustine—brain cancer	0.00111	0.00277	CcSEcCtD
Zuclopenthixol—Malnutrition—Carmustine—brain cancer	0.00111	0.00277	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Hydroxyurea—brain cancer	0.0011	0.00275	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Hydroxyurea—brain cancer	0.0011	0.00274	CcSEcCtD
Zuclopenthixol—Skin disorder—Hydroxyurea—brain cancer	0.00109	0.00272	CcSEcCtD
Zuclopenthixol—HTR2A—spinal cord—brain cancer	0.00109	0.00348	CbGeAlD
Zuclopenthixol—Perphenazine—CYP2C9—brain cancer	0.00109	0.0996	CrCbGaD
Zuclopenthixol—ADRA1A—brain—brain cancer	0.00108	0.00347	CbGeAlD
Zuclopenthixol—Mental disorder—Temozolomide—brain cancer	0.00108	0.0027	CcSEcCtD
Zuclopenthixol—Malnutrition—Temozolomide—brain cancer	0.00108	0.00268	CcSEcCtD
Zuclopenthixol—Erythema—Temozolomide—brain cancer	0.00108	0.00268	CcSEcCtD
Zuclopenthixol—Jaundice—Etoposide—brain cancer	0.00107	0.00267	CcSEcCtD
Zuclopenthixol—Anorexia—Hydroxyurea—brain cancer	0.00107	0.00267	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Procarbazine—brain cancer	0.00107	0.00267	CcSEcCtD
Zuclopenthixol—DRD2—brain—brain cancer	0.00106	0.0034	CbGeAlD
Zuclopenthixol—HRH1—central nervous system—brain cancer	0.00106	0.00338	CbGeAlD
Zuclopenthixol—Vision blurred—Carmustine—brain cancer	0.00105	0.00261	CcSEcCtD
Zuclopenthixol—Tremor—Carmustine—brain cancer	0.00104	0.0026	CcSEcCtD
Zuclopenthixol—Asthenia—Procarbazine—brain cancer	0.00104	0.0026	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Etoposide—brain cancer	0.00104	0.0026	CcSEcCtD
Zuclopenthixol—ADRA2A—central nervous system—brain cancer	0.00104	0.00332	CbGeAlD
Zuclopenthixol—Agranulocytosis—Etoposide—brain cancer	0.00103	0.00256	CcSEcCtD
Zuclopenthixol—Pruritus—Procarbazine—brain cancer	0.00103	0.00256	CcSEcCtD
Zuclopenthixol—Agitation—Carmustine—brain cancer	0.00102	0.00255	CcSEcCtD
Zuclopenthixol—ADRA2A—cerebellum—brain cancer	0.00101	0.00325	CbGeAlD
Zuclopenthixol—Vision blurred—Temozolomide—brain cancer	0.00101	0.00253	CcSEcCtD
Zuclopenthixol—Tremor—Temozolomide—brain cancer	0.00101	0.00251	CcSEcCtD
Zuclopenthixol—Dyspnoea—Hydroxyurea—brain cancer	0.001	0.0025	CcSEcCtD
Zuclopenthixol—Somnolence—Hydroxyurea—brain cancer	0.000999	0.00249	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Temozolomide—brain cancer	0.000998	0.00249	CcSEcCtD
Zuclopenthixol—Leukopenia—Carmustine—brain cancer	0.000997	0.00248	CcSEcCtD
Zuclopenthixol—Diarrhoea—Procarbazine—brain cancer	0.000994	0.00248	CcSEcCtD
Zuclopenthixol—Dyspepsia—Hydroxyurea—brain cancer	0.000989	0.00246	CcSEcCtD
Zuclopenthixol—Agitation—Temozolomide—brain cancer	0.000989	0.00246	CcSEcCtD
Zuclopenthixol—HTR2A—endocrine gland—brain cancer	0.000979	0.00313	CbGeAlD
Zuclopenthixol—Decreased appetite—Hydroxyurea—brain cancer	0.000977	0.00243	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Etoposide—brain cancer	0.000977	0.00243	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00097	0.00242	CcSEcCtD
Zuclopenthixol—Malaise—Temozolomide—brain cancer	0.00097	0.00242	CcSEcCtD
Zuclopenthixol—Urethral disorder—Etoposide—brain cancer	0.000969	0.00241	CcSEcCtD
Zuclopenthixol—Fatigue—Hydroxyurea—brain cancer	0.000969	0.00241	CcSEcCtD
Zuclopenthixol—HTR2A—head—brain cancer	0.000967	0.00309	CbGeAlD
Zuclopenthixol—Vertigo—Temozolomide—brain cancer	0.000967	0.00241	CcSEcCtD
Zuclopenthixol—Convulsion—Carmustine—brain cancer	0.000965	0.0024	CcSEcCtD
Zuclopenthixol—Leukopenia—Temozolomide—brain cancer	0.000963	0.0024	CcSEcCtD
Zuclopenthixol—Hypertension—Carmustine—brain cancer	0.000961	0.00239	CcSEcCtD
Zuclopenthixol—Pain—Hydroxyurea—brain cancer	0.000961	0.00239	CcSEcCtD
Zuclopenthixol—Constipation—Hydroxyurea—brain cancer	0.000961	0.00239	CcSEcCtD
Zuclopenthixol—Dizziness—Procarbazine—brain cancer	0.00096	0.00239	CcSEcCtD
Zuclopenthixol—Palpitations—Temozolomide—brain cancer	0.000951	0.00237	CcSEcCtD
Zuclopenthixol—Myalgia—Carmustine—brain cancer	0.000948	0.00236	CcSEcCtD
Zuclopenthixol—Anxiety—Carmustine—brain cancer	0.000945	0.00235	CcSEcCtD
Zuclopenthixol—Convulsion—Temozolomide—brain cancer	0.000932	0.00232	CcSEcCtD
Zuclopenthixol—Hypertension—Temozolomide—brain cancer	0.000929	0.00231	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Hydroxyurea—brain cancer	0.000926	0.00231	CcSEcCtD
Zuclopenthixol—Eye disorder—Etoposide—brain cancer	0.000924	0.0023	CcSEcCtD
Zuclopenthixol—Vomiting—Procarbazine—brain cancer	0.000923	0.0023	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Etoposide—brain cancer	0.000918	0.00229	CcSEcCtD
Zuclopenthixol—Clozapine—CYP2C9—brain cancer	0.000917	0.084	CrCbGaD
Zuclopenthixol—Myalgia—Temozolomide—brain cancer	0.000916	0.00228	CcSEcCtD
Zuclopenthixol—Rash—Procarbazine—brain cancer	0.000916	0.00228	CcSEcCtD
Zuclopenthixol—Dermatitis—Procarbazine—brain cancer	0.000915	0.00228	CcSEcCtD
Zuclopenthixol—Anxiety—Temozolomide—brain cancer	0.000913	0.00227	CcSEcCtD
Zuclopenthixol—Headache—Procarbazine—brain cancer	0.00091	0.00227	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00091	0.00227	CcSEcCtD
Zuclopenthixol—Discomfort—Temozolomide—brain cancer	0.000905	0.00225	CcSEcCtD
Zuclopenthixol—Angiopathy—Etoposide—brain cancer	0.000897	0.00224	CcSEcCtD
Zuclopenthixol—Dry mouth—Temozolomide—brain cancer	0.000896	0.00223	CcSEcCtD
Zuclopenthixol—Immune system disorder—Etoposide—brain cancer	0.000893	0.00223	CcSEcCtD
Zuclopenthixol—CYP2D6—endocrine gland—brain cancer	0.000892	0.00285	CbGeAlD
Zuclopenthixol—Thrombocytopenia—Carmustine—brain cancer	0.00089	0.00222	CcSEcCtD
Zuclopenthixol—Body temperature increased—Hydroxyurea—brain cancer	0.000889	0.00221	CcSEcCtD
Zuclopenthixol—Tachycardia—Carmustine—brain cancer	0.000887	0.00221	CcSEcCtD
Zuclopenthixol—HTR2A—central nervous system—brain cancer	0.000882	0.00282	CbGeAlD
Zuclopenthixol—CYP2D6—head—brain cancer	0.000881	0.00282	CbGeAlD
Zuclopenthixol—Anaphylactic shock—Temozolomide—brain cancer	0.000878	0.00219	CcSEcCtD
Zuclopenthixol—Anorexia—Carmustine—brain cancer	0.000866	0.00216	CcSEcCtD
Zuclopenthixol—Nausea—Procarbazine—brain cancer	0.000863	0.00215	CcSEcCtD
Zuclopenthixol—HTR2A—cerebellum—brain cancer	0.000862	0.00276	CbGeAlD
Zuclopenthixol—Nervous system disorder—Temozolomide—brain cancer	0.000861	0.00214	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Temozolomide—brain cancer	0.00086	0.00214	CcSEcCtD
Zuclopenthixol—Skin disorder—Temozolomide—brain cancer	0.000853	0.00212	CcSEcCtD
Zuclopenthixol—Hypotension—Carmustine—brain cancer	0.000849	0.00211	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Temozolomide—brain cancer	0.000849	0.00211	CcSEcCtD
Zuclopenthixol—HRH1—brain—brain cancer	0.000839	0.00268	CbGeAlD
Zuclopenthixol—Anorexia—Temozolomide—brain cancer	0.000837	0.00208	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Hydroxyurea—brain cancer	0.000828	0.00206	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Carmustine—brain cancer	0.000828	0.00206	CcSEcCtD
Zuclopenthixol—ADRA2A—brain—brain cancer	0.000824	0.00264	CbGeAlD
Zuclopenthixol—Insomnia—Carmustine—brain cancer	0.000822	0.00205	CcSEcCtD
Zuclopenthixol—Paraesthesia—Carmustine—brain cancer	0.000816	0.00203	CcSEcCtD
Zuclopenthixol—Dyspnoea—Carmustine—brain cancer	0.00081	0.00202	CcSEcCtD
Zuclopenthixol—Somnolence—Carmustine—brain cancer	0.000808	0.00201	CcSEcCtD
Zuclopenthixol—Asthenia—Hydroxyurea—brain cancer	0.000806	0.00201	CcSEcCtD
Zuclopenthixol—CYP2D6—central nervous system—brain cancer	0.000804	0.00257	CbGeAlD
Zuclopenthixol—Musculoskeletal discomfort—Temozolomide—brain cancer	0.0008	0.00199	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Etoposide—brain cancer	0.000799	0.00199	CcSEcCtD
Zuclopenthixol—Insomnia—Temozolomide—brain cancer	0.000794	0.00198	CcSEcCtD
Zuclopenthixol—Decreased appetite—Carmustine—brain cancer	0.00079	0.00197	CcSEcCtD
Zuclopenthixol—Paraesthesia—Temozolomide—brain cancer	0.000788	0.00196	CcSEcCtD
Zuclopenthixol—CYP2D6—cerebellum—brain cancer	0.000786	0.00251	CbGeAlD
Zuclopenthixol—Gastrointestinal disorder—Carmustine—brain cancer	0.000784	0.00195	CcSEcCtD
Zuclopenthixol—Dyspnoea—Temozolomide—brain cancer	0.000783	0.00195	CcSEcCtD
Zuclopenthixol—Somnolence—Temozolomide—brain cancer	0.000781	0.00194	CcSEcCtD
Zuclopenthixol—Pain—Carmustine—brain cancer	0.000777	0.00194	CcSEcCtD
Zuclopenthixol—Constipation—Carmustine—brain cancer	0.000777	0.00194	CcSEcCtD
Zuclopenthixol—Malaise—Etoposide—brain cancer	0.000776	0.00193	CcSEcCtD
Zuclopenthixol—Vertigo—Etoposide—brain cancer	0.000773	0.00193	CcSEcCtD
Zuclopenthixol—Dyspepsia—Temozolomide—brain cancer	0.000773	0.00193	CcSEcCtD
Zuclopenthixol—Leukopenia—Etoposide—brain cancer	0.000771	0.00192	CcSEcCtD
Zuclopenthixol—Diarrhoea—Hydroxyurea—brain cancer	0.000769	0.00192	CcSEcCtD
Zuclopenthixol—Decreased appetite—Temozolomide—brain cancer	0.000763	0.0019	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Temozolomide—brain cancer	0.000758	0.00189	CcSEcCtD
Zuclopenthixol—Fatigue—Temozolomide—brain cancer	0.000757	0.00189	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Etoposide—brain cancer	0.000757	0.00188	CcSEcCtD
Zuclopenthixol—Pain—Temozolomide—brain cancer	0.000751	0.00187	CcSEcCtD
Zuclopenthixol—Constipation—Temozolomide—brain cancer	0.000751	0.00187	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Carmustine—brain cancer	0.000749	0.00187	CcSEcCtD
Zuclopenthixol—Convulsion—Etoposide—brain cancer	0.000746	0.00186	CcSEcCtD
Zuclopenthixol—Hypertension—Etoposide—brain cancer	0.000743	0.00185	CcSEcCtD
Zuclopenthixol—Dizziness—Hydroxyurea—brain cancer	0.000743	0.00185	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Carmustine—brain cancer	0.000743	0.00185	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000728	0.00181	CcSEcCtD
Zuclopenthixol—Discomfort—Etoposide—brain cancer	0.000724	0.0018	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Temozolomide—brain cancer	0.000724	0.0018	CcSEcCtD
Zuclopenthixol—Abdominal pain—Carmustine—brain cancer	0.000718	0.00179	CcSEcCtD
Zuclopenthixol—Body temperature increased—Carmustine—brain cancer	0.000718	0.00179	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Temozolomide—brain cancer	0.000718	0.00179	CcSEcCtD
Zuclopenthixol—Vomiting—Hydroxyurea—brain cancer	0.000715	0.00178	CcSEcCtD
Zuclopenthixol—Rash—Hydroxyurea—brain cancer	0.000709	0.00177	CcSEcCtD
Zuclopenthixol—Dermatitis—Hydroxyurea—brain cancer	0.000708	0.00176	CcSEcCtD
Zuclopenthixol—Headache—Hydroxyurea—brain cancer	0.000704	0.00175	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Etoposide—brain cancer	0.000703	0.00175	CcSEcCtD
Zuclopenthixol—HTR2A—brain—brain cancer	0.0007	0.00224	CbGeAlD
Zuclopenthixol—Abdominal pain—Temozolomide—brain cancer	0.000694	0.00173	CcSEcCtD
Zuclopenthixol—Body temperature increased—Temozolomide—brain cancer	0.000694	0.00173	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Etoposide—brain cancer	0.000688	0.00171	CcSEcCtD
Zuclopenthixol—Tachycardia—Etoposide—brain cancer	0.000686	0.00171	CcSEcCtD
Zuclopenthixol—Skin disorder—Etoposide—brain cancer	0.000682	0.0017	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Etoposide—brain cancer	0.000679	0.00169	CcSEcCtD
Zuclopenthixol—Anorexia—Etoposide—brain cancer	0.00067	0.00167	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Carmustine—brain cancer	0.000669	0.00167	CcSEcCtD
Zuclopenthixol—Nausea—Hydroxyurea—brain cancer	0.000668	0.00166	CcSEcCtD
Zuclopenthixol—Hypotension—Etoposide—brain cancer	0.000657	0.00164	CcSEcCtD
Zuclopenthixol—Asthenia—Carmustine—brain cancer	0.000652	0.00162	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Temozolomide—brain cancer	0.000647	0.00161	CcSEcCtD
Zuclopenthixol—CYP2D6—brain—brain cancer	0.000638	0.00204	CbGeAlD
Zuclopenthixol—Paraesthesia—Etoposide—brain cancer	0.000631	0.00157	CcSEcCtD
Zuclopenthixol—Asthenia—Temozolomide—brain cancer	0.00063	0.00157	CcSEcCtD
Zuclopenthixol—Dyspnoea—Etoposide—brain cancer	0.000626	0.00156	CcSEcCtD
Zuclopenthixol—Somnolence—Etoposide—brain cancer	0.000625	0.00156	CcSEcCtD
Zuclopenthixol—Diarrhoea—Carmustine—brain cancer	0.000622	0.00155	CcSEcCtD
Zuclopenthixol—Pruritus—Temozolomide—brain cancer	0.000621	0.00155	CcSEcCtD
Zuclopenthixol—Decreased appetite—Etoposide—brain cancer	0.000611	0.00152	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Etoposide—brain cancer	0.000607	0.00151	CcSEcCtD
Zuclopenthixol—Fatigue—Etoposide—brain cancer	0.000606	0.00151	CcSEcCtD
Zuclopenthixol—Dizziness—Carmustine—brain cancer	0.000601	0.0015	CcSEcCtD
Zuclopenthixol—Pain—Etoposide—brain cancer	0.000601	0.0015	CcSEcCtD
Zuclopenthixol—Constipation—Etoposide—brain cancer	0.000601	0.0015	CcSEcCtD
Zuclopenthixol—Diarrhoea—Temozolomide—brain cancer	0.000601	0.0015	CcSEcCtD
Zuclopenthixol—Dizziness—Temozolomide—brain cancer	0.000581	0.00145	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Etoposide—brain cancer	0.000579	0.00144	CcSEcCtD
Zuclopenthixol—Vomiting—Carmustine—brain cancer	0.000578	0.00144	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Etoposide—brain cancer	0.000575	0.00143	CcSEcCtD
Zuclopenthixol—Rash—Carmustine—brain cancer	0.000573	0.00143	CcSEcCtD
Zuclopenthixol—Dermatitis—Carmustine—brain cancer	0.000572	0.00143	CcSEcCtD
Zuclopenthixol—Headache—Carmustine—brain cancer	0.000569	0.00142	CcSEcCtD
Zuclopenthixol—Vomiting—Temozolomide—brain cancer	0.000558	0.00139	CcSEcCtD
Zuclopenthixol—Body temperature increased—Etoposide—brain cancer	0.000555	0.00138	CcSEcCtD
Zuclopenthixol—Abdominal pain—Etoposide—brain cancer	0.000555	0.00138	CcSEcCtD
Zuclopenthixol—Rash—Temozolomide—brain cancer	0.000554	0.00138	CcSEcCtD
Zuclopenthixol—Dermatitis—Temozolomide—brain cancer	0.000553	0.00138	CcSEcCtD
Zuclopenthixol—Headache—Temozolomide—brain cancer	0.00055	0.00137	CcSEcCtD
Zuclopenthixol—Nausea—Carmustine—brain cancer	0.00054	0.00134	CcSEcCtD
Zuclopenthixol—Nausea—Temozolomide—brain cancer	0.000522	0.0013	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Etoposide—brain cancer	0.000518	0.00129	CcSEcCtD
Zuclopenthixol—Asthenia—Etoposide—brain cancer	0.000504	0.00126	CcSEcCtD
Zuclopenthixol—Pruritus—Etoposide—brain cancer	0.000497	0.00124	CcSEcCtD
Zuclopenthixol—Diarrhoea—Etoposide—brain cancer	0.000481	0.0012	CcSEcCtD
Zuclopenthixol—Dizziness—Etoposide—brain cancer	0.000465	0.00116	CcSEcCtD
Zuclopenthixol—Vomiting—Etoposide—brain cancer	0.000447	0.00111	CcSEcCtD
Zuclopenthixol—Rash—Etoposide—brain cancer	0.000443	0.0011	CcSEcCtD
Zuclopenthixol—Dermatitis—Etoposide—brain cancer	0.000443	0.0011	CcSEcCtD
Zuclopenthixol—Headache—Etoposide—brain cancer	0.00044	0.0011	CcSEcCtD
Zuclopenthixol—Nausea—Etoposide—brain cancer	0.000417	0.00104	CcSEcCtD
Zuclopenthixol—ADRA2A—Metabolism—IDH1—brain cancer	1.93e-05	0.000918	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—VAV1—brain cancer	1.92e-05	0.000912	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GLI1—brain cancer	1.9e-05	0.000903	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—VAV1—brain cancer	1.89e-05	0.000898	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SHH—brain cancer	1.88e-05	0.000897	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—VAV1—brain cancer	1.88e-05	0.000896	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GLI2—brain cancer	1.87e-05	0.000892	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—PIK3CG—brain cancer	1.87e-05	0.000891	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SUFU—brain cancer	1.87e-05	0.000888	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	1.85e-05	0.000879	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SUFU—brain cancer	1.84e-05	0.000874	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SUFU—brain cancer	1.83e-05	0.000872	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—TP53—brain cancer	1.82e-05	0.000867	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TRPC6—brain cancer	1.82e-05	0.000865	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GFAP—brain cancer	1.8e-05	0.000857	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SUFU—brain cancer	1.8e-05	0.000856	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PTCH1—brain cancer	1.79e-05	0.000851	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SMO—brain cancer	1.79e-05	0.000851	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GFAP—brain cancer	1.77e-05	0.000843	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GFAP—brain cancer	1.77e-05	0.000841	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—HES1—brain cancer	1.76e-05	0.000839	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GLI1—brain cancer	1.76e-05	0.000839	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—VAV1—brain cancer	1.74e-05	0.000829	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GFAP—brain cancer	1.73e-05	0.000826	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—PIK3CG—brain cancer	1.72e-05	0.000821	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CYP2C9—brain cancer	1.72e-05	0.000818	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—VAV1—brain cancer	1.72e-05	0.000817	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—VAV1—brain cancer	1.71e-05	0.000815	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—VAV1—brain cancer	1.71e-05	0.000814	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—IL2—brain cancer	1.71e-05	0.000813	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—HEY1—brain cancer	1.71e-05	0.000812	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—PIK3CG—brain cancer	1.7e-05	0.000809	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—HEY1—brain cancer	1.68e-05	0.000799	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—PDGFRA—brain cancer	1.68e-05	0.000799	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—VAV1—brain cancer	1.68e-05	0.000798	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—HEY1—brain cancer	1.68e-05	0.000798	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—DLL1—brain cancer	1.67e-05	0.000797	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SUFU—brain cancer	1.67e-05	0.000795	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NOTCH2—brain cancer	1.66e-05	0.00079	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—DLL1—brain cancer	1.65e-05	0.000784	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HEY1—brain cancer	1.64e-05	0.000783	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—DLL1—brain cancer	1.64e-05	0.000782	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—SPP1—brain cancer	1.63e-05	0.000776	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—DLL1—brain cancer	1.61e-05	0.000768	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—PIK3CG—brain cancer	1.61e-05	0.000767	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GFAP—brain cancer	1.61e-05	0.000767	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—VAV1—brain cancer	1.58e-05	0.000753	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—VAV1—brain cancer	1.56e-05	0.000742	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL2—brain cancer	1.55e-05	0.000738	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HEY1—brain cancer	1.53e-05	0.000727	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ENO2—brain cancer	1.52e-05	0.000725	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—DLL1—brain cancer	1.5e-05	0.000713	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IRS2—brain cancer	1.47e-05	0.000701	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—PIK3CG—brain cancer	1.46e-05	0.000697	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—BSG—brain cancer	1.46e-05	0.000695	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NOTCH2—brain cancer	1.43e-05	0.00068	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SHH—brain cancer	1.42e-05	0.000677	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SHH—brain cancer	1.4e-05	0.000667	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SHH—brain cancer	1.4e-05	0.000665	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TRPC6—brain cancer	1.37e-05	0.000653	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SHH—brain cancer	1.37e-05	0.000653	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—VAV1—brain cancer	1.36e-05	0.000648	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—HES1—brain cancer	1.36e-05	0.000648	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TRPC6—brain cancer	1.35e-05	0.000643	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SMO—brain cancer	1.35e-05	0.000642	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PTCH1—brain cancer	1.35e-05	0.000642	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TRPC6—brain cancer	1.35e-05	0.000641	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PTCH1—brain cancer	1.33e-05	0.000632	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SMO—brain cancer	1.33e-05	0.000632	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PTCH1—brain cancer	1.32e-05	0.000631	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SMO—brain cancer	1.32e-05	0.000631	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TRPC6—brain cancer	1.32e-05	0.000629	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—IL2—brain cancer	1.32e-05	0.000627	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—APC—brain cancer	1.3e-05	0.00062	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—PIK3CG—brain cancer	1.3e-05	0.00062	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SMO—brain cancer	1.3e-05	0.000619	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PTCH1—brain cancer	1.3e-05	0.000619	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PDGFRA—brain cancer	1.3e-05	0.000617	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SHH—brain cancer	1.27e-05	0.000606	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SPP1—brain cancer	1.26e-05	0.000599	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—IDH1—brain cancer	1.26e-05	0.000598	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TRPC6—brain cancer	1.23e-05	0.000585	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	1.22e-05	0.000579	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—IL2—brain cancer	1.21e-05	0.000577	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SMO—brain cancer	1.21e-05	0.000575	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PTCH1—brain cancer	1.21e-05	0.000575	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—PIK3CG—brain cancer	1.2e-05	0.00057	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL2—brain cancer	1.2e-05	0.00057	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	1.19e-05	0.000569	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—EGFR—brain cancer	1.19e-05	0.000564	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	1.17e-05	0.000558	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—HES1—brain cancer	1.17e-05	0.000558	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IRS2—brain cancer	1.14e-05	0.000541	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—IL2—brain cancer	1.13e-05	0.00054	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PDGFRA—brain cancer	1.12e-05	0.000531	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—PIK3CG—brain cancer	1.1e-05	0.000526	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	1.09e-05	0.000519	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	1.09e-05	0.000518	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—PIK3CG—brain cancer	1.08e-05	0.000517	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SPP1—brain cancer	1.08e-05	0.000515	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NOTCH2—brain cancer	1.08e-05	0.000513	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	1.06e-05	0.000507	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NOTCH2—brain cancer	1.06e-05	0.000505	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.06e-05	0.000504	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	1.04e-05	0.000495	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—VEGFA—brain cancer	1.03e-05	0.000491	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL2—brain cancer	1.03e-05	0.00049	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—VAV1—brain cancer	1.03e-05	0.000489	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—RELA—brain cancer	1.02e-05	0.000484	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—VAV1—brain cancer	1.01e-05	0.000482	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—ERBB2—brain cancer	1.01e-05	0.000481	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—VAV1—brain cancer	1.01e-05	0.000481	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PIK3CG—brain cancer	1e-05	0.000478	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—APC—brain cancer	1e-05	0.000478	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ENO2—brain cancer	9.93e-06	0.000473	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—VAV1—brain cancer	9.9e-06	0.000472	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	9.89e-06	0.000471	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IRS2—brain cancer	9.79e-06	0.000466	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	9.65e-06	0.00046	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—VAV1—brain cancer	9.2e-06	0.000438	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL2—brain cancer	9.16e-06	0.000436	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—EGFR—brain cancer	9.15e-06	0.000436	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CCND1—brain cancer	8.93e-06	0.000425	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—HES1—brain cancer	8.84e-06	0.000421	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CTNNB1—brain cancer	8.84e-06	0.000421	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—HES1—brain cancer	8.7e-06	0.000414	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—HES1—brain cancer	8.68e-06	0.000413	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PIK3CG—brain cancer	8.65e-06	0.000412	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—APC—brain cancer	8.65e-06	0.000412	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—IL2—brain cancer	8.56e-06	0.000408	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HES1—brain cancer	8.52e-06	0.000406	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—IL2—brain cancer	8.43e-06	0.000401	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PDGFRA—brain cancer	8.42e-06	0.000401	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—IL2—brain cancer	8.41e-06	0.0004	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PDGFRA—brain cancer	8.28e-06	0.000394	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PDGFRA—brain cancer	8.27e-06	0.000394	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL2—brain cancer	8.25e-06	0.000393	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SPP1—brain cancer	8.17e-06	0.000389	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	8.11e-06	0.000386	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SPP1—brain cancer	8.04e-06	0.000383	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SPP1—brain cancer	8.02e-06	0.000382	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HES1—brain cancer	7.91e-06	0.000377	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—EGFR—brain cancer	7.88e-06	0.000375	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SPP1—brain cancer	7.87e-06	0.000375	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—RELA—brain cancer	7.85e-06	0.000374	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ERBB2—brain cancer	7.8e-06	0.000371	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TP53—brain cancer	7.79e-06	0.000371	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—VEGFA—brain cancer	7.78e-06	0.000371	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL2—brain cancer	7.78e-06	0.00037	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—STAT3—brain cancer	7.71e-06	0.000367	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL2—brain cancer	7.67e-06	0.000365	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL2—brain cancer	7.65e-06	0.000364	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL2—brain cancer	7.63e-06	0.000363	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	7.54e-06	0.000359	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL2—brain cancer	7.49e-06	0.000357	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IRS2—brain cancer	7.39e-06	0.000352	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SPP1—brain cancer	7.32e-06	0.000348	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IRS2—brain cancer	7.27e-06	0.000346	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IRS2—brain cancer	7.26e-06	0.000346	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MYC—brain cancer	7.16e-06	0.000341	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IRS2—brain cancer	7.12e-06	0.000339	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL2—brain cancer	7.07e-06	0.000337	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—EGFR—brain cancer	7e-06	0.000333	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PIK3CG—brain cancer	6.99e-06	0.000333	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL2—brain cancer	6.96e-06	0.000331	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCND1—brain cancer	6.89e-06	0.000328	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CTNNB1—brain cancer	6.82e-06	0.000325	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—RELA—brain cancer	6.76e-06	0.000322	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ERBB2—brain cancer	6.71e-06	0.00032	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IRS2—brain cancer	6.62e-06	0.000315	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—APC—brain cancer	6.53e-06	0.000311	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PIK3CG—brain cancer	6.53e-06	0.000311	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PIK3CG—brain cancer	6.42e-06	0.000306	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APC—brain cancer	6.42e-06	0.000306	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PIK3CG—brain cancer	6.41e-06	0.000305	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APC—brain cancer	6.41e-06	0.000305	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	6.29e-06	0.000299	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APC—brain cancer	6.29e-06	0.000299	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL2—brain cancer	6.08e-06	0.00029	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—VEGFA—brain cancer	6.01e-06	0.000286	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—STAT3—brain cancer	5.95e-06	0.000283	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—EGFR—brain cancer	5.95e-06	0.000283	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCND1—brain cancer	5.93e-06	0.000282	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TP53—brain cancer	5.88e-06	0.00028	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CTNNB1—brain cancer	5.87e-06	0.00028	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—EGFR—brain cancer	5.85e-06	0.000279	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APC—brain cancer	5.84e-06	0.000278	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	5.84e-06	0.000278	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—EGFR—brain cancer	5.84e-06	0.000278	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—EGFR—brain cancer	5.73e-06	0.000273	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MYC—brain cancer	5.53e-06	0.000263	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—EGFR—brain cancer	5.41e-06	0.000257	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—EGFR—brain cancer	5.32e-06	0.000253	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—VEGFA—brain cancer	5.17e-06	0.000246	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—STAT3—brain cancer	5.12e-06	0.000244	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RELA—brain cancer	5.1e-06	0.000243	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ERBB2—brain cancer	5.07e-06	0.000241	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RELA—brain cancer	5.02e-06	0.000239	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RELA—brain cancer	5.01e-06	0.000238	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ERBB2—brain cancer	4.99e-06	0.000237	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ERBB2—brain cancer	4.98e-06	0.000237	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RELA—brain cancer	4.91e-06	0.000234	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ERBB2—brain cancer	4.88e-06	0.000232	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MYC—brain cancer	4.76e-06	0.000227	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—EGFR—brain cancer	4.65e-06	0.000222	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL2—brain cancer	4.59e-06	0.000219	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RELA—brain cancer	4.57e-06	0.000217	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PIK3CG—brain cancer	4.55e-06	0.000217	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TP53—brain cancer	4.54e-06	0.000216	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ERBB2—brain cancer	4.54e-06	0.000216	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL2—brain cancer	4.52e-06	0.000215	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL2—brain cancer	4.51e-06	0.000215	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCND1—brain cancer	4.48e-06	0.000213	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CTNNB1—brain cancer	4.43e-06	0.000211	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL2—brain cancer	4.43e-06	0.000211	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCND1—brain cancer	4.41e-06	0.00021	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCND1—brain cancer	4.4e-06	0.000209	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CTNNB1—brain cancer	4.36e-06	0.000208	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CTNNB1—brain cancer	4.35e-06	0.000207	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCND1—brain cancer	4.31e-06	0.000205	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	4.27e-06	0.000203	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL2—brain cancer	4.11e-06	0.000196	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCND1—brain cancer	4.01e-06	0.000191	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	3.97e-06	0.000189	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TP53—brain cancer	3.91e-06	0.000186	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—VEGFA—brain cancer	3.9e-06	0.000186	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—STAT3—brain cancer	3.87e-06	0.000184	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—VEGFA—brain cancer	3.84e-06	0.000183	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—VEGFA—brain cancer	3.83e-06	0.000182	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—STAT3—brain cancer	3.8e-06	0.000181	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—STAT3—brain cancer	3.8e-06	0.000181	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—VEGFA—brain cancer	3.76e-06	0.000179	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—STAT3—brain cancer	3.72e-06	0.000177	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MYC—brain cancer	3.59e-06	0.000171	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MYC—brain cancer	3.53e-06	0.000168	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MYC—brain cancer	3.53e-06	0.000168	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—EGFR—brain cancer	3.51e-06	0.000167	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—VEGFA—brain cancer	3.49e-06	0.000166	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MYC—brain cancer	3.46e-06	0.000165	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—STAT3—brain cancer	3.46e-06	0.000165	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—EGFR—brain cancer	3.46e-06	0.000165	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—EGFR—brain cancer	3.45e-06	0.000164	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—EGFR—brain cancer	3.38e-06	0.000161	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MYC—brain cancer	3.22e-06	0.000153	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—EGFR—brain cancer	3.14e-06	0.00015	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TP53—brain cancer	2.95e-06	0.00014	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TP53—brain cancer	2.9e-06	0.000138	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TP53—brain cancer	2.9e-06	0.000138	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TP53—brain cancer	2.84e-06	0.000135	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TP53—brain cancer	2.64e-06	0.000126	CbGpPWpGaD
